XENETIC BIOSCIENCES INC
XBIO · NASDAQ
更新於 2026-10-15 08:35:28
$2.10+0.00%
- 今日最高
- $2.14
- 今日最低
- $2.07
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
...
K線圖趨勢，實際資料以交易頁為準
關鍵數據
- 昨天開盤價
- $2.07
- 昨天收盤價
- $2.10
- 成交量
- 12.57K
- 市值
- $5.84M
- 市盈率（P/E）
- --
- 每股收益（EPS）
- $-1.20
昨天價格區間
$2.07$2.14
52週價格區間
$1.87$6.51
公司概況
- 板塊
- 醫療保健
- 行業
- 生物科技
- 子行業
- 生物科技
- 總部
- 945 CONCORD STREET, FRAMINGHAM, MA, UNITED STATES, 01701
- 國家
- 美國
- 上市日期
- 2016-11-07
- 財年截止
- 十二月
- 流通股數
- 2.29M
- CIK
- 0001534525
Xenetic Biosciences, Inc. 是一家生物製藥公司，專注於推進 XCART，這是一種定制的嵌合抗原受體 T 細胞（CAR T）平台技術，旨在靶向患者特異性腫瘤新抗原。公司總部位於馬薩諸塞州弗雷明漢。
財務指標
營業收入
2026-06-30
$660.6K
2026-03-31
$806.92K
2025-12-31
$766.29K
2025-09-30
$1.02M
營業支出
2026-06-30
$1.63M
2026-03-31
$1.3M
2025-12-31
$1.38M
2025-09-30
$1.57M
淨利潤
2026-06-30
-$929.69K
2026-03-31
-$456.38K
2025-12-31
-$579.07K
2025-09-30
-$509.93K
淨利潤率
2026-06-30
-140.73%
2026-03-31
-56.55%
2025-12-31
-75.56%
2025-09-30
-49.65%
每股收益
2026-06-30
$-0.41
2026-03-31
$-0.19
2025-12-31
$-0.22
2025-09-30
$-0.33
息稅折舊攤銷前利潤
2026-06-30
-$929.69K
2026-03-31
-$456.38K
2025-12-31
-$579.07K
2025-09-30
-$509.93K
有效稅率
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| 項目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 營業收入 | $660.6K | $806.92K | $766.29K | $1.02M |
| 營業支出 | $1.63M | $1.3M | $1.38M | $1.57M |
| 淨利潤 | -$929.69K | -$456.38K | -$579.07K | -$509.93K |
| 淨利潤率 | -140.73% | -56.55% | -75.56% | -49.65% |
| 每股收益 | $-0.41 | $-0.19 | $-0.22 | $-0.33 |
| 息稅折舊攤銷前利潤 | -$929.69K | -$456.38K | -$579.07K | -$509.93K |
| 有效稅率 | -- | -- | -- | -- |
常見問題
風險提示
股價可能大幅波動，短時間內可能出現顯著漲跌。 數位資產與衍生性商品交易可能涉及槓桿、流動性等額外風險。 本頁內容僅供參考，不構成任何投資建議。 產品可用性與訪問可能因地區及適用法規而異。